BT Lab
SKU:BT-AP11483
NAA16 Rabbit Polyclonal Antibody
NAA16 Rabbit Polyclonal Antibody
Couldn't load pickup availability
NAA16 Rabbit Polyclonal Antibody
The NAA16 Rabbit Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of N-alpha-acetyltransferase 16 (NAA16) protein in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to a region within the NAA16 protein sequence.
NAA16 is a member of the N-alpha-acetyltransferase family, which plays a crucial role in protein acetylation, a post-translational modification that regulates protein function and stability. NAA16 specifically catalyzes the acetylation of the N-terminal methionine residue of newly synthesized proteins, thereby influencing their cellular localization, stability, and interaction with other molecules.
The NAA16 Rabbit Polyclonal Antibody has been extensively validated for its specificity and sensitivity in various experimental applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits minimal cross-reactivity with other related proteins, ensuring accurate and reliable results.
This antibody is supplied as a liquid formulation, purified from rabbit serum using protein A affinity chromatography. It is provided in a convenient size of 100 µg, allowing for multiple experiments and applications. The NAA16 Rabbit Polyclonal Antibody is suitable for use in both research and diagnostic settings, enabling the investigation of NAA16 protein expression and its functional implications in various biological processes.
With its high specificity, sensitivity, and versatility, the NAA16 Rabbit Polyclonal Antibody is an indispensable tool for researchers and clinicians studying protein acetylation and its role in cellular processes. Its reliable performance and consistent results make it an ideal choice for a wide range of applications, contributing to the advancement of scientific knowledge and the development of therapeutic strategies targeting NAA16-related pathways.
Share
